DRI Healthcare Trust Announces Voting Results of AGM
TORONTO, May 11, 2022/CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 11, 2022. All of the nominees for election as trustees of the Trust referred to in its management information circular dated March 25, 2022 were elected to serve as trustees for the ensuing year, and Deloitte LLP was reappointed as auditors of the Trust.
Election of Trustees
Voting results for the election of each trustee were as follows:
Trustee
Votes "for" as a percentage of votes cast for or withheld for the trustee
Votes "withheld" as a percentage of votes cast for or withheld for the trustee
Gary Collins
99.96%
0.04%
Ali Hedayat
94.59%
5.41%
Behzad Khosrowshahi
99.99%
0.01%
Kevin Layden
94.59%
5.41%
Paul Mussenden
80.11%
19.89%
Sandra Stuart
85.77%
14.23%
Tamara Vrooman
99.96%
0.04%
Appointment of Auditors
Unitholders also voted in favour of reappointing Deloitte LLP as auditors of the Trust and authorizing the board of trustees to fix their remuneration (99.998% in favour).
About DRI Healthcare Trust
DRI Healthcare Trust provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Our business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties with the aim to deliver attractive growth in cash royalty receipts over the long term. DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario, externally managed by its manager, DRI Capital Inc. DRI Healthcare Trust's units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol "DHT.UN" and in U.S. dollars under the symbol "DHT.U".
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, will showcase significant contributions in preclinical and translational oncology research at the American Association for Cancer Research (AACR) 2024...
HFA Architecture + Engineering has expanded its healthcare design team with the addition of Principal and Healthcare Practice Leader Paul Sabal (AIA, ACHA, NCARB, LEED AP).
Sabal is a registered architect and interior designer with more than four...
NanoVibronix, Inc. ("NanoVibronix" or the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered into an...
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported financial...
Soapy Joe's Car Wash, an award-winning and family-owned car wash operator with 23 locations, today announced April 18, 2024, as the ninth annual Soapy Joe's Day and will celebrate by offering the public free Magic Joe car washes ($20 value) and aims...